Ortivus AB (publ) (ORTI-A.ST)
SEK 2.8
(6.06%)
SEK 2.8
(6.06%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 4.19 Million SEK | 404.43% |
| 2022 | -1.37 Million SEK | 92.68% |
| 2021 | -18.8 Million SEK | 10.97% |
| 2020 | -21.11 Million SEK | -284.19% |
| 2019 | -5.49 Million SEK | -156.88% |
| 2018 | 9.66 Million SEK | 15.93% |
| 2017 | 8.33 Million SEK | -53.77% |
| 2016 | 18.03 Million SEK | -21.12% |
| 2015 | 22.86 Million SEK | 506.13% |
| 2014 | -5.62 Million SEK | 28.7% |
| 2013 | -7.89 Million SEK | 61.38% |
| 2012 | -20.44 Million SEK | -49.49% |
| 2011 | -13.67 Million SEK | 51.39% |
| 2010 | -28.13 Million SEK | -329.61% |
| 2009 | -6.54 Million SEK | 69.83% |
| 2008 | -21.7 Million SEK | 39.13% |
| 2007 | -35.65 Million SEK | 35.86% |
| 2006 | -55.59 Million SEK | -407.72% |
| 2005 | 18.06 Million SEK | 126.5% |
| 2004 | -68.17 Million SEK | 27.84% |
| 2003 | -94.48 Million SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 11.71 Million SEK | 179.53% |
| 2024 Q2 | 17.19 Million SEK | 46.75% |
| 2023 FY | 4.19 Million SEK | 404.43% |
| 2023 Q1 | -171 Thousand SEK | 87.58% |
| 2023 Q2 | 2.88 Million SEK | 1784.21% |
| 2023 Q3 | 21.97 Million SEK | 662.99% |
| 2023 Q4 | 4.19 Million SEK | -80.92% |
| 2022 Q4 | -1.37 Million SEK | 74.16% |
| 2022 FY | -1.37 Million SEK | 92.68% |
| 2022 Q3 | -5.32 Million SEK | 65.09% |
| 2022 Q1 | -24.67 Million SEK | -31.25% |
| 2022 Q2 | -15.26 Million SEK | 38.15% |
| 2021 FY | -18.8 Million SEK | 10.97% |
| 2021 Q3 | -2.19 Million SEK | 86.49% |
| 2021 Q1 | -23.94 Million SEK | -13.36% |
| 2021 Q2 | -16.27 Million SEK | 32.03% |
| 2021 Q4 | -18.8 Million SEK | -755.41% |
| 2020 Q3 | -27.19 Million SEK | 14.03% |
| 2020 Q1 | -20.29 Million SEK | -269.15% |
| 2020 Q2 | -31.63 Million SEK | -55.89% |
| 2020 FY | -21.11 Million SEK | -284.19% |
| 2020 Q4 | -21.11 Million SEK | 22.34% |
| 2019 Q1 | 5.74 Million SEK | -40.61% |
| 2019 FY | -5.49 Million SEK | -156.88% |
| 2019 Q2 | -9.15 Million SEK | -259.55% |
| 2019 Q3 | -523 Thousand SEK | 94.29% |
| 2019 Q4 | -5.49 Million SEK | -951.05% |
| 2018 Q1 | 424 Thousand SEK | -94.91% |
| 2018 Q4 | 9.66 Million SEK | 6.97% |
| 2018 FY | 9.66 Million SEK | 15.93% |
| 2018 Q3 | 9.03 Million SEK | 1.81% |
| 2018 Q2 | 8.87 Million SEK | 1992.92% |
| 2017 Q1 | -811 Thousand SEK | -104.5% |
| 2017 Q2 | -5.93 Million SEK | -631.81% |
| 2017 Q4 | 8.33 Million SEK | 486.33% |
| 2017 FY | 8.33 Million SEK | -53.77% |
| 2017 Q3 | -2.15 Million SEK | 63.64% |
| 2016 Q2 | 2.98 Million SEK | -12.51% |
| 2016 FY | 18.03 Million SEK | -21.12% |
| 2016 Q1 | 3.4 Million SEK | -85.1% |
| 2016 Q4 | 18.03 Million SEK | 1203.9% |
| 2016 Q3 | 1.38 Million SEK | -53.59% |
| 2015 Q2 | 5.29 Million SEK | 279.54% |
| 2015 Q4 | 22.86 Million SEK | 247.64% |
| 2015 Q1 | -2.94 Million SEK | 47.65% |
| 2015 FY | 22.86 Million SEK | 506.13% |
| 2015 Q3 | 6.57 Million SEK | 24.29% |
| 2014 Q4 | -5.62 Million SEK | 4.79% |
| 2014 FY | -5.62 Million SEK | 28.7% |
| 2014 Q3 | -5.91 Million SEK | -43.32% |
| 2014 Q2 | -4.12 Million SEK | 6.55% |
| 2014 Q1 | -4.41 Million SEK | 44.09% |
| 2013 Q3 | -10.03 Million SEK | 26.9% |
| 2013 Q1 | -16.76 Million SEK | 18.02% |
| 2013 Q4 | -7.89 Million SEK | 21.35% |
| 2013 FY | -7.89 Million SEK | 61.38% |
| 2013 Q2 | -13.73 Million SEK | 18.07% |
| 2012 Q1 | -12.35 Million SEK | 9.64% |
| 2012 Q2 | -12.17 Million SEK | 1.48% |
| 2012 Q3 | -15.97 Million SEK | -31.25% |
| 2012 FY | -20.44 Million SEK | -49.49% |
| 2012 Q4 | -20.44 Million SEK | -27.95% |
| 2011 Q4 | -13.67 Million SEK | 33.58% |
| 2011 FY | -13.67 Million SEK | 51.39% |
| 2011 Q1 | -23.32 Million SEK | 17.08% |
| 2011 Q2 | -10.5 Million SEK | 54.96% |
| 2011 Q3 | -20.58 Million SEK | -95.94% |
| 2010 FY | -28.13 Million SEK | -329.61% |
| 2010 Q4 | -28.13 Million SEK | 0.0% |
| 2009 FY | -6.54 Million SEK | 69.83% |
| 2008 FY | -21.7 Million SEK | 39.13% |
| 2007 FY | -35.65 Million SEK | 35.86% |
| 2006 FY | -55.59 Million SEK | -407.72% |
| 2005 FY | 18.06 Million SEK | 126.5% |
| 2004 FY | -68.17 Million SEK | 27.84% |
| 2003 FY | -94.48 Million SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AddLife AB (publ) | 5.01 Billion SEK | 99.916% |
| Biotage AB (publ) | -444 Million SEK | 100.944% |
| Bonesupport Holding AB (publ) | -149.86 Million SEK | 102.797% |
| Doxa AB (publ) | -102.2 Million SEK | 104.102% |
| Elekta AB (publ) | 4.46 Billion SEK | 99.906% |
| iZafe Group AB (publ) | -2.65 Million SEK | 257.653% |
| Ortivus AB (publ) | 4.19 Million SEK | 0.0% |
| Q-linea AB (publ) | -61.33 Million SEK | 106.835% |
| S2Medical AB (publ) | -1.51 Million SEK | 376.33% |
| Synsam AB (publ) | 2.67 Billion SEK | 99.843% |